Skip to main content
Publications
Goyal RK, Jain P, Nagar SP, Le H, Kabadi SM, Davis K, Kaye JA, Du XL, Wang M. Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma. Leuk Lymphoma. 2021 Jun;62(6):1325-34. doi: 10.1080/10428194.2021.1919662
Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod L, Wolowacz S, Kaye JA, Kontoudis I. Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: a retrospective and prospective observational study (MELABIS). Int J Clin Pract. 2017 May 16;71(5):e12946. doi: 10.1111/ijcp.12946
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR. Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States. Leuk Lymphoma. 2015 May;56(5):1295-302. doi: 10.3109/10428194.2014.953144
Payne JR, Eleftheriou KI, James LE, Hawe E, Mann J, Stronge A, Kotwinski P, World M, Humphries SE, Pennell DJ, Montgomery HE. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart. Heart. 2006;92(12):1784-8.
Palka P, Lange A, Fleming AD, Starkey IR, Fenn LN, Shaw TRD, Fox KAA, McDicken WN, Sutherland GR. Transmural velocity gradients-A new ultrasonic index for hypertrophic cardiomyopathy hearts. Poster presented at the British Cardiac Society Annual Meeting; May 7, 1996. Glasgow, Scotland. [abstract] Heart. 1996 May 1; 75(5 Suppl 1):21. doi: 10.1136/hrt.75.5_Suppl_1.P6